纳米颗粒团聚,nano-particle aggregation
1)nano-particle aggregation纳米颗粒团聚
2)agglomeration of nano-size particles纳米颗粒聚团
3)fluidized agglomerate of nano-size particles纳米颗粒团聚物
4)silver nanoclusters银纳米团簇颗粒
1.Using the flow-levitation method prepared thesilver nanoclusters by controlling and rectifying the experimentation condition and correlative parameters.采用自悬浮定向流法制备银纳米团簇颗粒,通过对实验条件及相关参数的控制与调整,并用XRD、TEM和UV-vis等分析手段对其进行表征。
5)chitosan nanoparticle壳聚糖纳米颗粒
1.Then the recombinant VR1C was entrapped withchitosan nanoparticles(CNP) prepared by the method of ionic cross linkage,and employed to inject muscularly 3-weeks old Kunming mice.为研制安全高效免疫调节剂增强动物免疫抗病能力,本实验设计合成含11个CpG基序的寡聚核苷酸,重组构建含CpG的VR1012质粒(VR1C);制备壳聚糖纳米颗粒包裹重组质粒(CNP-VR1C),肌注接种3周龄昆明小鼠;接种后28天口服大肠杆菌攻毒观察小鼠天然免疫的变化和对强毒感染的抵抗力,Sandwich ELISA测定血清免疫球蛋白和白细胞介素含量。
2.The recombinant eukaryotic expression plasmid with the porcine IL-2 gene and CpG motifs were entrapped withchitosan nanoparticles(CNP) prepared by the method of ionic cross linkage,designa-ted as CNP-VRIL2S-VR1C,and then were injected intramuscularly into pigs at 0.将改组的猪白细胞介素-2基因(VRIL2S)与重组CpG(VR1C)质粒经离子交联法制备的壳聚糖纳米颗粒(CNP)包裹后(CNP-VRIL2S-VR1C),肌肉注射给已接种猪伪狂犬病灭活疫苗的免疫猪,接种后第7、14、28、42和56d采集静脉血检测猪的免疫应答变化,并测定血清免疫球蛋白和白细胞介素含量。
3.Then the recombinant VR1C was entrapped with Chitosan nanoparticles (CNP) prepared by the method of ionic cross linkage, and employed to inject muscularly 3-weeks old Kunming mice; the blank VR1012 packed with CNP and saline were used to inoculate mice a.为研制安全高效免疫调节剂增强动物免疫抗病能力，本实验设计合成含11个C pG基序的寡聚核苷酸，重组构建含CpG的VR1012质粒(VR1C)；制备壳聚糖纳米颗粒包裹重组质粒(CNP-VR1C)，肌注接种3周龄昆明小白鼠，设壳聚糖包裹空质粒和生理盐水对照组；接种后28天口服大肠杆菌攻毒观察小鼠天然免疫的变化和对强毒感染的抵抗力，Sandwich ELISA测定血清免疫球蛋白和白细胞介素含量。
英文短句/例句
1.A Preliminary Study on the mPEG-Chitosan Nanoparticles as Gene Delivery Vehicles and Protein CarriersmPEG-壳聚糖纳米颗粒作为基因与蛋白载体的初步研究
2.Chitosan Nanoparticle as Gene Vehicle Mediated by Particle Bombardment in Onion Cell Transformation基于壳聚糖纳米颗粒的基因枪法转化洋葱细胞研究
3.Preliminary Studies on Preparation and Application of Chitosan Nanoparticles as the Nonviral Gene Delivery Vehicle;壳聚糖—基因疫苗纳米颗粒的制备与作用研究
4.Research of Hepatitis B Vaccines Based on Chitosan Derivative Nanoparticles;壳聚糖衍生物纳米颗粒在乙肝疫苗中的应用研究
5.Photocatalytic degradation kinetics of Biebrich Red by chitosan/nano-CdS composite particle壳聚糖/纳米CdS复合颗粒可见光光催化降解猩红B动力学研究
6.Preparation and analysis of chitosan nanoparticles loaded with SiRNAsiRNA/壳聚糖纳米粒的制备和分析
7.Study of preparation of chitosan micro-/nano-particles and their characteristics壳聚糖微纳米粒制备及其特性的研究
8.Studies on Enteric-coated Insulin-chitosan Complex Nanoparticles;肠溶包衣胰岛素—壳聚糖复合物纳米粒的研究
9.Preparation and Characterization of Chitosan/5-fluorouracil Nanoparticles;壳聚糖/5-氟尿嘧啶纳米粒子制备及性能评价
10.Modification of Chitosan and Praparation and Characterization of Nanoparticle Drug Carriers;壳聚糖的修饰及纳米载药粒子的制备与表征
11.Preparation and Characterization of Chitosan Microspheres/Nanoparticles;壳聚糖微球/纳米粒的制备及其性能研究
12.The Study of the Effect of Molecular Structure of Chitosan on Character of Norcantharidin Chitosan Nanoparticles in Vitro and in Vivo;分子参数对壳聚糖纳米粒体内外性质影响研究
13.Study on Thymopentin Loaded Oral N-trimethyl Chitosan Nanopartic;胸腺五肽三甲基壳聚糖口服纳米粒的研究
14.Chitosan-DNA Nanoparticles as Non-viral Delivery Systems;壳聚糖纳米粒作为基因治疗载体的研究
15.Effect of Swine Ghrelin Gene Delivered by Chitosan Nanoparticles on the Growth of Mice;壳聚糖纳米粒介导猪Ghrelin基因对小鼠生长的影响
16.Research of Loading-Norcantharidin Low Molecular Weight Chitosan Nanoparticles;去甲基斑蝥素低分子量壳聚糖纳米粒研究
17.Studies on Chitosan Modifying TFu Solid Lipid Nanoparticle壳聚糖修饰TFu固体脂质纳米粒的初步研究
18.The Empirical Study of Hepatocellular Carcinoma"s Gene Therapy Using hTERTp-TK/GCV Which was Mediated by Chitosan壳聚糖纳米粒介导的hTERTp-TK/GCV靶向抗肝癌研究
相关短句/例句
agglomeration of nano-size particles纳米颗粒聚团
3)fluidized agglomerate of nano-size particles纳米颗粒团聚物
4)silver nanoclusters银纳米团簇颗粒
1.Using the flow-levitation method prepared thesilver nanoclusters by controlling and rectifying the experimentation condition and correlative parameters.采用自悬浮定向流法制备银纳米团簇颗粒,通过对实验条件及相关参数的控制与调整,并用XRD、TEM和UV-vis等分析手段对其进行表征。
5)chitosan nanoparticle壳聚糖纳米颗粒
1.Then the recombinant VR1C was entrapped withchitosan nanoparticles(CNP) prepared by the method of ionic cross linkage,and employed to inject muscularly 3-weeks old Kunming mice.为研制安全高效免疫调节剂增强动物免疫抗病能力,本实验设计合成含11个CpG基序的寡聚核苷酸,重组构建含CpG的VR1012质粒(VR1C);制备壳聚糖纳米颗粒包裹重组质粒(CNP-VR1C),肌注接种3周龄昆明小鼠;接种后28天口服大肠杆菌攻毒观察小鼠天然免疫的变化和对强毒感染的抵抗力,Sandwich ELISA测定血清免疫球蛋白和白细胞介素含量。
2.The recombinant eukaryotic expression plasmid with the porcine IL-2 gene and CpG motifs were entrapped withchitosan nanoparticles(CNP) prepared by the method of ionic cross linkage,designa-ted as CNP-VRIL2S-VR1C,and then were injected intramuscularly into pigs at 0.将改组的猪白细胞介素-2基因(VRIL2S)与重组CpG(VR1C)质粒经离子交联法制备的壳聚糖纳米颗粒(CNP)包裹后(CNP-VRIL2S-VR1C),肌肉注射给已接种猪伪狂犬病灭活疫苗的免疫猪,接种后第7、14、28、42和56d采集静脉血检测猪的免疫应答变化,并测定血清免疫球蛋白和白细胞介素含量。
3.Then the recombinant VR1C was entrapped with Chitosan nanoparticles (CNP) prepared by the method of ionic cross linkage, and employed to inject muscularly 3-weeks old Kunming mice; the blank VR1012 packed with CNP and saline were used to inoculate mice a.为研制安全高效免疫调节剂增强动物免疫抗病能力，本实验设计合成含11个C pG基序的寡聚核苷酸，重组构建含CpG的VR1012质粒(VR1C)；制备壳聚糖纳米颗粒包裹重组质粒(CNP-VR1C)，肌注接种3周龄昆明小白鼠，设壳聚糖包裹空质粒和生理盐水对照组；接种后28天口服大肠杆菌攻毒观察小鼠天然免疫的变化和对强毒感染的抵抗力，Sandwich ELISA测定血清免疫球蛋白和白细胞介素含量。
6)Chitosan nanoparticles壳聚糖纳米颗粒
1.In order to develop a safe and effective immunoadjuvant to enhance the immunity of human to resist HBV infection,an novel CpG Oligodeoxynucleotides(CpG ODN) containing 11 CpG motifs was synthesized and entrapped with chitosan nanoparticles(CNP) which prepared by ionic cross linkage method,and employed to intramuscular injection on 6 weeks old Kunming mice with 5 μg HBsAg vaccine/ capita.为探索高效安全的分子免疫增强剂,本实验设计合成含11个CpG基序的寡聚核苷酸(CpG ODN),制备壳聚糖纳米颗粒包裹CpG ODN,研究新型CpG ODN壳聚糖纳米颗粒(CpG-CNP)对人乙型肝炎疫苗的免疫佐剂效应。
延伸阅读
看纺织印染中应用纳米材料和纳米技术纺织印染中应用纳米材料和纳米技术时，除了要解决纳米材料的制备技术之外，重要的是要解决好纳米材料的应用技术，其中关键问题是使纳米粒子和纺织印染材料的基本成分（即聚合物材料）之间处于适当的结合状态。印染中，纳米粒子在聚合物基体中的分散和纳米粒子在聚合物表面的结合是主要的应用技术问题。 制备聚合物/无机纳米复合材料的直接分散法，适用于各种形态的纳米粒子。印染中纳米粒子的使用一般采用直接分散法。但是由于纳米粒子存在很大的界面自由能，粒子极易自发团聚，利用常规的共混方法不能消除无机纳米粒子与聚合物基体之间的高界面能差。因此，要将无机纳米粒子直接分散于有机基质中制备聚合物纳米复合材料，必须通过必要的化学预分散和物理机械分散打开纳米粒子团聚体，将其均匀分散到聚合物基体材料中并与基体材料有良好的亲和性。直接分散法可通过以下途径完成分散和复合过程： 高分子溶液（或乳液）共混：首先将聚合物基体溶解于适当的溶剂中制成溶液（或乳液），然后加入无机纳米粒子，利用超声波分散或其他方法将纳米粒子均匀分散在溶液（或乳液）中。有人将环氧树脂溶于丙酮后加入经偶联剂处理过的纳米TiO2，搅拌均匀，再加入 40wt%的聚酰胺后固化制得了环氧树脂/TiO2纳米复合材料。还有人将纳米SiO2粒子用硅烷偶联剂处理后，改性不饱和聚酯。 熔融共混：将纳米无机粒子与聚合物基体在密炼机、双螺杆等混炼机械上熔融共混。如将PMMA和纳米SiO2粒子熔融共混后，双螺杆造粒制得纳米复合材料。又如利用偶联剂超声作用下处理纳米载银无机抗菌剂粒子，分散制得PP/抗菌剂、PET/抗菌剂、PA/抗菌剂等复合树脂，然后经熔融纺丝工艺加工成抗菌纤维。研究表明，将经过表面处理的纳米抗菌剂粒子通过双螺杆挤出机熔融混炼，在聚合物中可以达到纳米尺度分散，获得了具有良好综合性能的纳米抗菌纤维，对大肠杆菌、金黄色葡萄球菌的抗菌率达到95%以上（美国AATCC－100标准）。 机械共混：将偶联剂稀释后与碳纳米管混合，再与超高分子量聚乙烯（UHMWPE）混合放入三头研磨机中研磨两小时以上。将研磨混合物放入模具，热压，制得功能型纳米复合材料。 聚合法：利用纳米SiO2粒子填充（Poly（HEMA））制备了纳米复合材料。纳米SiO2粒子首先被羟乙基甲基丙烯酸（HEMA）功能化，然后与HEMA单体在悬浮体系中聚合。还有利用SiO2胶体表面带酸性，加入碱性单体4－乙烯基吡咯进行自由基聚合制得包覆型纳米复合材料。
